📰 Assay Development News
Page 6 - Assay Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Assay Development. Real-time updates on events, politics, business and more.
August 1, 2023
Dr. Anne Wyllie is renowned for her work developing tests to detect SARS-CoV-2 in individuals suspected of COVID-19
July 31, 2023
Dr. Anne Wyllie is renowned for her work developing tests to detect SARS-CoV-2 in individuals suspected of COVID-19
July 17, 2023
Growing awareness of the gap in coordination and resources for plant disease diagnostic assay development and validation inspired Kitty Cardwell—Director of the Institute for Biosecurity and Microbial Forensics at Oklahoma State University—and colleagues, in collaboration with The American Phytopathological Society (APS), to publish the focus issue “Diagnostic Assay Development and Validation: The Science of Getting It Right” in the journal PhytoFrontiers. This visionary and widely colla...
June 5, 2023
Astria Therapeutics, Inc. , a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and... | June 5, 2023
April 4, 2023
Data Bridge Market research has published a report on the "Cancer Nanotherapy Market," which analyzes major regions including USA, Europe, China, Japan, India,
March 27, 2023
Dublin, March 27, 2023 (GLOBE NEWSWIRE) -- The "Glycobiology: Global Markets for Diagnostics and Therapeutics" report has been added to ...
February 27, 2023
In this article, News-Medical talks to Sartorius about biosensing and bioprocessing in gene therapy, while also discussing the various products Sartorius produces in order to aid in this.
February 27, 2023
Discover the benefits of working with a raw material supplier who also supports the development of lateral flow assays
January 26, 2023
Cancer Biomarkers Market study by "Data Bridge Market Research" provides details about the market dynamics affecting this market, Market scope, Market
December 27, 2022

Data Bridge Market Research analyses that the cancer biomarkers market which was USD 4.15 billion in 2022, would rocket up to USD 9.56 billion by 2030,